Home » Topics » Regulatory » Patents

Patents
RSS

Novel IDO-1 inhibitors discovered at GlaxoSmithKline

Nov. 27, 2017

AstraZeneca presents novel ataxia telangiectasia mutated kinase inhibitors

Nov. 24, 2017

Boehringer Ingelheim patents semicarbazide-sensitive amine oxidase inhibitors

Nov. 24, 2017

New proteinase-activated PAR2 receptor antagonists identified at AstraZeneca

Nov. 24, 2017

Esteve describes novel dual voltage-gated calcium channel ligands and NET inhibitors

Nov. 24, 2017

New vasopressin receptor antagonists presented by Bayer

Nov. 23, 2017

Immunovaccine discloses vaccine compositions for cancer

Nov. 23, 2017

Fochon Pharma presents novel CDK4/6 inhibitors

Nov. 23, 2017

Sage Therapeutics discloses novel NMDA receptor modulators

Nov. 23, 2017

Shionogi & Co. patents new AMPK activators for diabetes

Nov. 23, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...